Loading...
Immunosuppression in inflammatory bowel disease: how much is too much?
PURPOSE OF REVIEW: Current treatment approaches favor the early introduction of immunomodulators and/or antitumor necrosis factor (TNF) agents. There is now strong evidence showing that combination therapy appears to be more effective than monotherapy in both ulcerative colitis and Crohn’s disease....
Saved in:
| Published in: | Curr Opin Gastroenterol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681654/ https://ncbi.nlm.nih.gov/pubmed/22573191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOG.0b013e328354567f |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|